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A B S T R A C T
This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows:
To determine the diagnostic accuracy of abdominal ultrasound as a standalone test for detecting abdominal TB or disseminated TB
with abdominal involvement in HIV-positive adults.
• To determine the diagnostic accuracy of combinations of abdominal ultrasound and existing tests (chest radiograph, full blood
count) for detecting abdominal TB or disseminated TB with abdominal involvement in HIV-positive adults.
• To investigate potential sources of heterogeneity in test accuracy, including clinical setting, ultrasound training level, and type of
reference standard.
B A C K G R O U N D
Target condition being diagnosed
Tuberculosis (TB) is caused by the bacillus Mycobacterium tuber-
culosis. Although it usually affects the lungs (pulmonary TB), it
can also spread to other body sites (extrapulmonary TB) (WHO
2013a).
An estimated 10.4 million people were diagnosed with TB in
2015 and 1.8 million people died due to TB (WHO 2016b).
Resource-limited countries are the most affected, for example, the
African region of the World Health Organization (WHO) had
the second highest number of incident cases (2.7 million), but the
1Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive
adults (Protocol)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
highest incidence rate (275 versus 142 globally) and mortality rate
(HIV-positive: 30 versus 5.3 globally; HIV-negative: 45 versus 19
globally) per 100,000 people (WHO 2016b).
The probability of developing TB is higher among people living
withHIV. Approximately 1.1million people diagnosedworldwide
with TB in 2015 were HIV-positive (WHO 2016b), while the
HIV prevalence among incident TB cases in the African region
was 31% (WHO 2016b).
The worldwide case detection rate in 2015 was only an estimated
59% (WHO 2016b). This low rate of detection relates to prob-
lems with TB diagnostic tests (sensitivity, specificity, and availabil-
ity), the negative influence of HIV infection on the performance
of diagnostic tests, and HIV co-infection and the opportunis-
tic conditions that complicate it (Palmieri 2002; Dawson 2010;
Padmapriyadarsini 2011; Steingart 2014; WHO 2016a). The di-
agnosis of active TB in HIV-positive patients with advanced im-
munosuppression is challenging due to more atypical clinical pre-
sentations; other opportunistic pulmonary infections with similar
presentations; high proportion negative sputum smears; and high
rates of extrapulmonary TB (Sharma 2005). This is illustrated by
autopsy studies, which indicate a very high proportion of TB in
HIV-positive adults (32% to 47%); almost half (46%) of adult
TB cases remained undiagnosed premortem (Gupta 2015).
In people with HIV-associated TB, extrapulmonary TB accounts
for up to 50% of all TB cases (Sharma 2004b; Kingkaew 2009;
Namme 2013), and is often disseminated (two or more non-
contiguous sites simultaneously infected) (Sharma 2005). Any
anatomical site can be involved, but the commonest sites are the
lymphnodes, pleura,meninges, and the abdominal cavity (Sharma
2005). Many terms are used in the literature to describe TB in
the abdominal cavity. For the purpose of this Cochrane Review,
we will use the terms abdominal TB or disseminated TB with
abdominal involvement - excluding genitourinary TB. Many ab-
dominal structures can be affected in abdominal TB or dissemi-
nated TB with abdominal involvement, including involvement of
the gastrointestinal tract, peritoneum, omentum, mesentery, in-
tra-abdominal lymph nodes, and solid organs (liver, spleen, pan-
creas) (Sharma 2004b). Patients often present with non-specific
symptoms and signs, and a high index of suspicion is therefore
needed for early diagnosis and timely management. It mimics a
large number of medical and surgical conditions, including ma-
lignant neoplasms, inflammatory bowel disease, chronic liver dis-
ease, and other gastrointestinal infections (Jadvar 1997).
Index test(s)
Many HIV-positive people with low CD4 counts have abdominal
TB or disseminated TB with abdominal involvement. As sputum
smears are frequently negative in HIV-associated TB, it is com-
mon clinical practice, supported byWHO guidelines, to reach TB
diagnosis on the basis of imaging results and clinical case defini-
tions (Wilson 2006; WHO 2016a). Ultrasound is such an imag-
ing test that can be used as a diagnostic tool (Heller 2010a; Heller
2010b; Patel 2011; Giordani 2013). Ultrasound uses sound waves
to produce images of structures and organs within the body, and is
particularly relevant in low-resource settings as it is more accessible
and cheaper than using computed tomography (CT). Ultrasound
techniques for TB diagnosis are also easily learned and quick to
perform (less than 10 minutes) (Heller 2010a).
Abdominal ultrasound (an ultrasound examination evaluating the
abdominal cavity) is useful in HIV-positive patients with sus-
pected abdominal TB or disseminated TB with abdominal in-
volvement. Suggestive findings include lymphadenopathy, ascites,
and focal liver and splenic lesions (Heller 2010a; Heller 2010b;
Patel 2011; Giordani 2013). However, the ultrasound findings are
non-specific and various other diseases may present with the same
features. For example, intra-abdominal lymphadenopathy can be
due to other infections (for example, cryptococcosis, histoplasmo-
sis); lymphomas (non-Hodgkin’s lymphoma and Hodgkin’s lym-
phoma); and Kaposi’s sarcoma (Martin-Bates 1993).
Clinical pathway
Any structure or organ in the abdominal cavity (for example,
gastrointestinal tract, pancreatobiliary system, peritoneum, and
lymph nodes) can be affected by TB disease. The presentation
varies considerably and depends on the specific organ involved;
other diseases are also often mimicked (Sharma 2004a). Com-
mon presenting symptoms are abdominal pain, anorexia, bowel
disturbances, fever, and weight loss; whereas the clinical examina-
tion often reveals abdominal tenderness, ascites, and solid organ
enlargement (for example, hepatomegaly, splenomegaly, or hep-
atosplenomegaly) (Ibrahim 2005; Mandal 2011).
Essential diagnostic tests, as suggested by the WHO for individ-
uals who are suspected of having abdominal TB or disseminated
TB with abdominal involvement, include a chest x-ray, sputum
evaluation (if able to produce) for bacteriological confirmation of
TB disease (smear or culture or Xpert MTB/RIF), and blood cul-
tures (WHO 2013b). Urine specimens remain a convenient clin-
ical sample for the diagnosis of TB. Although conventional TB
diagnostics applied to urine specimens have limited clinical utility,
the use of urinary lipoarabinomannan (LAM) has been recom-
mended by the WHO in HIV-positive adults with advanced im-
munosuppression (CD4 cell count less than or equal to 100 cells/
µL) or in HIV-positive adults who are seriously ill (respiratory rate
> 30/min, temperature > 39°C, heart rate > 120/min and unable
to walk unaided) regardless of their CD4 cell count (WHO 2015;
Shah 2016). These tests are usually done in the primary care set-
ting and higher.
Abdominal ultrasound has become part of the initial diagnostic
work up in adults livingwithHIVwhere abdominal TB or dissem-
inated TB with abdominal involvement is suspected (especially in
those with a lowCD4 count), despite the lack of robust evidence of
validity from large studies (NICE 2016). The diagnostic pathway
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might differ in different settings if there are ultrasound findings
suggestive of TB. In low-resource settings this might be enough
evidence to initiate anti-TB treatment, but in high-resource set-
tings it would prompt site-specific investigations which could in-
clude CT scan, paracentesis, laparoscopy, fine needle aspiration,
or stool examination.
A presumptive diagnosis of abdominal TB or disseminated TB
with abdominal involvement can be made in the setting of known
active pulmonary TB, although less than half of chest radiographs
are compatible with active or healed TB (Chow 2002).
Routine laboratory studies are nonspecific and include a mild
normocytic and normochromic anaemia, hypoalbuminaemia, and
raised erythrocyte sedimentation rate (Kapoor 1998; Chow 2002;
Sharma 2004a). A normal leukocyte count is present in most pa-
tients. However, the WHO further recommends immediate ini-
tiation of anti-TB therapy in patients living with HIV who have
clinical features of disseminated TB (WHO 2016a). Bacteriolog-
ical confirmation of TB from any specimen remains important
but treatment should not be delayed until results become avail-
able (Figure 1). Patients started on anti-TB therapy without bac-
teriological confirmation should be assessed after one month to
evaluate the clinical response to treatment. Patients should be re-
assessed and an alternative diagnosis sought if there is no clinical
improvement.
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Figure 1. Diagnostic workup of HIV-positive adults with suspected abdominal tuberculosis or disseminated
tuberculosis with abdominal involvement
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Alternative test(s)
Ascitic fluid analysis suggestive of abdominal TB or disseminated
TBwith abdominal involvement includes a leukocyte count of 150
to 4000 cells/mL, which consists predominantly of lymphocytes
(Sharma 2004a; Sanai 2005). The ascitic fluid is usually an exudate
with the protein content greater than 30 g/L and the serum-ascites
albumin gradient (SAAG) less than 11 g/L (Sharma 2004a; Sanai
2005). Adenosine deaminase activity (ADA) of ascitic fluid (> 39
IU/L) is also suggestive of abdominal TB (Riquelme 2006), while
the ascites to blood glucose ratio is usually less than 0.96 (Wilkins
1984). Acid-Fast Bacilli (AFB) smear and culture of ascitic fluid
also have disappointingly low yields (Chow 2003).
Different imaging modalities can be useful to diagnose abdominal
TB or disseminated TB with abdominal involvement. Abdominal
x-rays are of very limited value, but can assist with the diagnosis of
intestinal obstruction and perforation (Debi 2014). CT features
include thickening of the peritoneum, omentum, and bowel wall;
lymph nodes (especially if these have hypodense centres due to
caseous necrosis); and ascites with strands, debris, and fine sep-
tations (Sharma 2004a; Lee 2012). The excellent soft tissue reso-
lution and multiplanar acquisition of Magnetic Resonance Imag-
ing (MRI) resulted in it being used to evaluate solid organs and
lymphadenopathy (Joshi 2014). However, MRI is expensive and
access is very limited in low-resource settings. Barium studies may
be useful for intrinsic bowel abnormalities such as strictures, fis-
tulae, and erosions (Sharma 2004a; Debi 2014).
Colonoscopy with biopsy is a useful non-operative diagnostic pro-
cedure to obtain material for histology and culture (Kim 1998).
Mucosal nodules and transverse ulcers in the bowel are very sug-
gestive of TB, with definitive results obtained from tissue sent for
polymerase chain reaction (PCR), Ziehl-Neelsen stain, and culture
(Kim 1998; Sharma 2004a). Laparoscopy is useful in two ways:
(i) it allows visual inspection of the peritoneum; and (ii) it permits
specimens for histology, AFB stain, and culture to be obtained.
However, imaging modalities as described above provide a safer
and less expensive alternative, but may be less specific since they
are unable to provide a definitive microbiological diagnosis (Sanai
2005).
Expanded clinical case definitions were developed to diagnose
smear-negative TB inHIV-positive patients living in low-resource
settings (Wilson 2006), including abdominal TB or disseminated
TB with abdominal involvement (Wilson 2006; WHO 2016a).
For example, a patient presenting with symptoms and signs sug-
gestive of abdominal TB or disseminated TB with abdominal in-
volvement can be started on antituberculous treatment if the as-
citic fluid consists of a lymphocytic exudate along with either a
fever ≥ 38°C on two occasions or drenching sweats for greater
than two weeks (Wilson 2006). In this study, the positive predic-
tive value for abdominal lymph nodes diagnosed by ultrasound
was 94% (Wilson 2006). Augmented by the use of objective crite-
ria to monitor response to treatment within the first eight weeks,
this approach has reasonable diagnostic accuracy (Wilson 2006).
Rationale
Rapid, simple, inexpensive, and accurate diagnostic tests for TB
in general and TB in HIV-positive patients are needed. The value
of diagnostic tests for TB in HIV-positive patients is that they
may be able to reduce both time to TB treatment initiation and
inappropriate use of empiric TB treatment. The latter is associated
with unnecessary costs, inconvenience, and potential adverse drug
reactions of antituberculous treatment (Wilson 2006).
The accurate diagnosis of TB in HIV-positive patients is diffi-
cult as is evident by the poor global case detection rate (WHO
2016b). Many HIV-positive people with low CD4 counts have
abdominal TB or disseminated TB with abdominal involvement.
Ultrasound can be a useful diagnostic tool to identify abdominal
TB or disseminated TB with abdominal involvement. Ultrasound
is non-invasive, portable, inexpensive, and safe. It is widely avail-
able in low-resource settings that have limited access to CT and
MRI scanners (Heller 2010a). Multiple studies of various qual-
ity and designs have looked at the use of abdominal ultrasound
as a diagnostic tool for abdominal TB or disseminated TB with
abdominal involvement; with varying sensitivity, specificity, and
predictive values for diagnosing TB (Monill-Serra 1997; Mugala
2006; Sinkala 2009; Sculier 2010; Patel 2011; Heller 2013). Ab-
dominal ultrasound may be used alone, in combination with ex-
isting tests (chest radiograph, full blood count), or as an add-on
following negative results from existing tests (smear microscopy,
sputum Xpert MTB/RIF, sputum culture, chest radiograph). The
role of abdominal ultrasound as an add-on test is an important
clinical question because it may reflect the way that abdominal
ultrasound is used in practice, especially in low-resource settings.
However, after a scoping search, we did not find any studies that
have evaluated the accuracy of ultrasound as an add-on test. There-
fore, this Cochrane Review will address the accuracy of ultrasound
used alone or in combination with other tests.
O B J E C T I V E S
To determine the diagnostic accuracy of abdominal ultrasound as
a standalone test for detecting abdominal TB or disseminated TB
with abdominal involvement in HIV-positive adults.
Secondary objectives
5Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive
adults (Protocol)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
• To determine the diagnostic accuracy of combinations of
abdominal ultrasound and existing tests (chest radiograph, full
blood count) for detecting abdominal TB or disseminated TB
with abdominal involvement in HIV-positive adults.
• To investigate potential sources of heterogeneity in test
accuracy, including clinical setting, ultrasound training level, and
type of reference standard.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include cross-sectional, cohort, or diagnostic case-con-
trol studies (prospective and retrospective) that compare the re-
sult of the index tests (abdominal ultrasound and abdominal ul-
trasound plus existing tests) with one of the reference standards
(see Reference standards). We will include conference abstracts if
we can obtain the required data (as specified below). Case-control
studies may overestimate sensitivity and specificity, but because we
anticipate identifying few relevant studies, we will include them.
If there is a sufficient number of studies, we will examine the effect
of excluding case-control studies in sensitivity analyses. We will
include studies in which the study authors report the numbers of
true positives (TP), true negatives (TN), false positives (FP), and
false negatives (FN), or which we can derive from reported statis-
tics, or obtain from the study authors. We will exclude descriptive
studies (for example, case series).
Participants
Wewill include all HIV-positive adults (≥ 18 years) with a clinical
suspicion of abdominal TB or disseminated TB with abdominal
involvement (excluding genitourinary TB), who were investigated
using an abdominal ultrasound examination. We will also con-
sider studies that include confirmed cases of abdominal TB and
controls. We will not place any restrictions on setting. Although
abdominal ultrasound can be used to evaluate children, microbi-
ological confirmation of TB is far more difficult than in adults,
and so we will exclude children.
Index tests
We will include studies that evaluate the accuracy of abdominal
ultrasound. We will not place any restrictions on the type of ultra-
sound machine used or the qualification of the person performing
the ultrasound, but we will record these data. A positive result
will be an ultrasound scan with abnormal findings suggestive of
abdominal TB or disseminated TB with abdominal involvement
including - but not limited to - free abdominal fluid, abdominal
lymph nodes, hepatic lesions, and splenic lesions. A negative result
will be an ultrasound scan with no abnormal findings.
We will deem test combinations as positive if the abdominal ul-
trasound is positive and either the chest x-ray or the full blood
count are positive. We will deem the chest x-ray to be positive if
any radiological features are suggestive of TB. A negative result
will be a chest x-ray with no radiological features suggestive of TB.
We will consider a full blood count to be positive if a normocytic
(mean corpuscular volume 80 to 100 fl) anaemia (haemoglobin
less than 13 g/dL in men, or less than 12 g/dL in women) were
present (WHO 2008).
Target conditions
Active disease due to M. tuberculosis - either abdominal TB or
disseminated TB with abdominal involvement.
Reference standards
We will use a hierarchy of reference standards. The reference stan-
dard diagnosis typically relates to microbiological confirmation
(microscopy or culture), although histopathological characteris-
tics strongly support a diagnosis of active TB in clinically and
epidemiologically appropriate settings. Xpert MTB/RIF assay (an
automated nucleic acid amplification test) can also identify M.
tuberculosis. A clinical diagnosis of TB is sometimes used in the
absence of confirmative tests, for example, probable TB can be de-
fined as the clinical picture of TB without objective diagnostic TB
criteria and treated for TB by the attending physician. Although
this approach is clinically useful, it is very subjective as it relies on
the clinical gestalt of the treating physician. It is therefore seen as
a lower quality reference standard.
The primary (higher quality) reference standard will be bacterio-
logical confirmation of any clinical specimen including (i) at least
one specimen culture positive forM. tuberculosis, (ii) microscopic
identification of AFB on stained sputum smears, lymph node as-
pirate, or any other specimen; or iii) Xpert MTB/RIF positive
(WHO 2013a). We will consider a positive result on any of these
tests as a positive result for the microbiological (higher quality)
reference standard and a TB case, since not all of the tests might
have been performed or might have a positive result. The reference
standard will be either solid or liquid culture for M. tuberculosis
complex (Lawn 2011). The sensitivity of smear microscopy can
be increased by examining more than one sample, using fluores-
cence microscopy, and using physical and chemical sputum pro-
cessing techniques including centrifugation, sedimentation, and
bleach (Steingart 2006a; Steingart 2006b). We will therefore in-
clude studies that use any of these techniques.
The secondary (lower quality) reference standard will be clinical
diagnosis ofTBwithoutmicrobiological confirmation. A clinically
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diagnosed TB case is one that has been diagnosed with active TB
by a healthcare practitioner and anti-TB therapy has subsequently
been initiated. This definition lacks bacteriological confirmation
but includes cases diagnosed on the basis of suggestive histol-
ogy (necrotising granulomatous inflammation), x-ray abnormal-
ities, and extrapulmonary cases without laboratory confirmation
(WHO 2013a). Using clinical diagnosis as a reference standard
could potentially bias test accuracy because abdominal ultrasound
is often used to inform the clinical decision to treat for TB. We
will include these studies as incorporation bias had a small effect
in diagnostic accuracy estimates (Rutjes 2006). However, we will
assess the impact of incorporation bias with a sensitivity analysis
and have also adapted the revised tool for the Quality Assessment
of Diagnostic Accuracy Studies (QUADAS-2)
Search methods for identification of studies
Electronic searches
We will search the electronic databases, MEDLINE, Embase,
BIOSIS, and MEDION. The MEDLINE search strategy is out-
lined in Appendix 1. We will further translate the MEDLINE
search to Embase and BIOSIS databases to identify additional
records. To avoid missing studies, we will not use a diagnostic
search filter or restrict searches by date or language.
Searching other resources
We will examine the reference lists of relevant reviews and studies;
and search web sites of the WHO, the Stop TB Partnership, and
theNational Institute of Allergy and Infectious Diseases (NIAID).
We will also perform forward citation searching of relevant articles
using the PubMed related articles feature, Google Scholar, and
ISI citation indices. Furthermore, where necessary we will contact
study authors for additional information.
Data collection and analysis
Selection of studies
Two review authors (DJvH and RG) will independently judge
study eligibility by examining the title and abstract of each arti-
cle identified by the literature search and will exclude obviously
irrelevant studies. If either review authors considers the abstract
to be potentially eligible, we will obtain the full-text article. The
two review authors will independently assess each full-text article
against the predefined inclusion and exclusion criteria as discussed
in the Criteria for considering studies for this review’ section.
The two review authors will resolve any disagreements by discus-
sion. If the review authors cannot reach consensus, a third review
author (GrM) will have the final decision. We will list all articles
excluded after full-text assessment and their reasons for exclusion
in the Characteristics of excluded studies’ table. We will illus-
trate the study selection process using a PRISMA diagram.
Data extraction and management
Two review authors (DJvH and RG) will independently extract
data using a pre designed data extraction form.
We will extract the following data.
• Authors, publication year, and journal.
• Study design.
• Characteristics study participants (age and gender).
• Study inclusion/exclusion criteria.
• Study setting.
• TB prevalence in study setting.
• HIV prevalence in study setting.
• Antiretroviral therapy (ART) status.
• Reference standard (bacteriological, clinical).
• Index test - general: abdominal ultrasound normal or
abnormal.
• Index test - specific: individual findings on ultrasound.
• Additional tests (and their results).
• Training level of person performing the ultrasound.
• Number of indeterminate, missing or unavailable test
results.
• Number of TP, TN, FP, and FN.
We will resolve any discrepancies in data extraction by discussion.
If needed, we will consult a third review author (GrM). We will
contact the authors of primary studies if we cannot resolve any
disagreements. In the event that this is unsuccessful, we will report
the disagreement in the review.
Assessment of methodological quality
We will use the revised tool for the Quality Assessment of Diag-
nostic Accuracy Studies (QUADAS-2) to assess the risk of bias
and applicability of included studies (Whiting 2011).We have tai-
lored the tool to the context of the review as shown in Appendix 2.
Two review authors (DJvH and RG) will independently assess the
methodological quality using the tailored QUADAS-2 tool. We
will resolve any disagreements through consensus or by consulting
a third review author (EAO). We will use both graphics and text
to present results.
Statistical analysis and data synthesis
Patients are highly likely to have more than one abnormal finding
per ultrasound. In our primary analyses, we will use the individual
patient as the unit of analysis (that is, any abnormal finding versus
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none) and not individual ultrasound findings. Clinically, it is also
useful to know the accuracy of individual ultrasound findings as
it is plausible that some findings are better indicators of TB than
others. Therefore, if there is sufficient data, we will consider the
accuracy of individual ultrasound findings in secondary analyses.
In these analyses, the patient will still be the unit of analysis as
in each analysis we will examine a single finding per patient (for
example, free abdominal fluid present or not) rather thanmultiple
findings per patient.
Studies are likely to use different criteria or thresholds to deter-
mine the positivity of ultrasound. For example, studies may de-
fine an ultrasound scan as positive based on the presence of any
abnormal abdominal finding including (but not limited to) organ
enlargement, the presence or number of hepatic or splenic lesions,
or the presence or size of abdominal nodes. We will construct 2
x 2 tables using the criteria specified in the studies. We will per-
form preliminary analyses by plotting estimates of sensitivity and
specificity from the included studies on forest plots and in receiver
operating characteristic (ROC) space using the software, Review
Manager 5 (RevMan 5) (RevMan 2014).
If there are sufficient data, we will perform meta-analyses using
hierarchical models. To allow for differences in thresholds between
studies, we will use the hierarchical summary ROC (HSROC)
model to estimate summary ROC (SROC) curves (Rutter 2001).
If studies use a common positivity criteria or threshold, we will
estimate summary sensitivities and specificities (summary points)
using functions of the parameters of the HSROC model. Alter-
natively, we will use the bivariate model if estimation of summary
points is more appropriate given the nature of the data. We will
fit the HSROC model using the statistical software SAS version
9.4 (SAS 2016) and the bivariate model using Stata 15 (STATA
2015). If analyses using hierarchical models fail to converge due to
sparse data or few studies, we will simplify the models as appropri-
ate based on the focus of inference (summary curves or summary
points) (Takwoingi 2015).
Investigations of heterogeneity
Potential sources of heterogeneity include type of reference stan-
dard (higher quality versus lower quality), clinical setting (primary
care clinic versus hospital), and ultrasound training level (radiol-
ogist versus sonographer). We will use these factors as categorical
covariates on forest plots and SROC plots for visual assessment
of heterogeneity. If sufficient data are available, we will investigate
the effect of each covariate by performing subgroup analyses or
meta-regression. We will perform meta-regression by including a
covariate in a hierarchical model.
Sensitivity analyses
If there are sufficient data, we will perform sensitivity analyses to
examine the influence of risk of bias and study design on test ac-
curacy. We will examine the impact of risk of bias in each of the
four QUADAS-2 domains (patient selection, index test, reference
standard, and flow and timing) by excluding studies at high or
unclear risk of bias from the main analyses. To examine the effect
of study design, we will exclude case-control studies. To assess the
impact of incorporation bias, we will exclude studies that incor-
porated the index test on the summary estimates.
Assessment of reporting bias
We will not assess reporting bias.
Assessment of the quality of evidence (certainty of the evi-
dence)
We will use the Grading of Recommendations Assessment, De-
velopment and Evaluation (GRADE) approach (GRADE 2013)
and GRADEpro Guideline Development Tool (GDT) software
(GRADEpro GDT 2015) to assess the certainty of evidence (also
called the quality of evidence). We will rate the quality of evidence
as either high (not downgraded), moderate (downgraded by one
level), low (downgraded by two levels), or very low (downgraded
by more than two levels) for five domains: risk of bias, indirect-
ness, inconsistency, imprecision, and publication bias.
For each outcome, the quality of evidence will start as high if there
are high quality observational studies (cross-sectional or cohort
studies) that enrolled participants with diagnostic uncertainty.We
will, if indicated, use our judgement to classify the reason for
downgrading as either serious (downgraded by one level) or very
serious (downgraded by two levels).
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy (OVID)
1 extrapulmonary tuberculosis.mp.
2 Peritonitis, Tuberculous/ or Tuberculosis, Gastrointestinal/ or Tuberculosis, Hepatic/
3 abdominal tuberculosis.mp.
4 Tuberculosis, Hepatic/ or liver tuberculosis.mp. or gastric tuberculosis.mp or intestinal tuberculosis.mp
5 Tuberculosis, Miliary/
6 disseminated tuberculosis.mp.
7 1 or 2 or 3 or 4 or 5 or 6
8 HIV infection.mp. or HIV Infections/
9 exp HIV/
10 human immunodeficiency virus.mp.
11 Acquired Immunodeficiency Syndrome/ or acquired immunodeficiency syndrome.mp.
12 (acquired immun* and deficiency syndrome).mp.
13 (HIV* adj2 (people or person* or patient*)).mp. or PLHIV.mp
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14 8 or 9 or 10 or 11 or 12 or 13
15 7 and 14
16 Abdomen/us [Ultrasonography]
17 Radiography/ or (X-ray*).mp
18 ultrasound.mp. or barium.mp
19 Tomography, X-Ray Computed/
20 (comput* adj2 tomograph*).mp.
21 Magnetic Resonance Imaging/
22 (MRI or CAT).mp.
23 Ultrasonography/ or ultrasonograph*.mp.
24 Bacteriological Techniques/ or Sputum/ or sputum specimen.mp.
25 liquid culture system.mp.
26 Xpert MTB*.mp.
27 Genotype MTBDR*.mp.
28 lipoarabinomannan.mp. or LAM.mp or LF-LAM.mp
29 (QuantiFERON-TB-Gold). mp or Tuberculin Test/ or tuberculin.mp
30 Diagnostic Imaging/ or Point-of-Care Systems/
31 CD4 Lymphocyte Count/ or (CD4 adj2 (cells or lymphocytes).mp
32 Laparotomy.mp or laparoscopy.mp or (fine needle aspiration).mp
33 Ascites/diagnosis or Ascites/microbiology or Paracentesis/ or Laparoscopy/
34 colonoscopy.mp. or Colonoscopy/
35 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or
31 or 32 or 33 or 34
36 15 and 35
This is the preliminary search strategy for MEDLINE (OVID), which we will adapt to search other electronic databases. We will report
all search strategies in full in the final version of the review.
Appendix 2. QUADAS-2 tool tailored to the context of the review
Domain Patient selection Index test Reference standard Flow and timing
Description Methods of patient se-
lection
How index
test was conducted and
reported
How reference stan-
dard was conducted
and reported
Describe patients that
did not receive and
time interval between
index test or reference
standard
Signalling questions
(yes, no, or unclear)
Consecutive or random
sample of patients?
• Yes if the study
reported consecutive
enrolment or random
sampling of patients.
• No if patients were
purposefully selected,
for example based on
previous test results
(other tests or reference
standard).
Index test results inter-
preted without knowl-
edge of the results of ref-
erence standard?
• Yes if it is apparent
that ultrasound (and
test combinations)
results were interpreted
without knowledge of
reference standard
results.
• No if results of
Reference standard likely
to correctly classify the
target condition?
• Yes if the higher
quality reference
standard was used (that
is, culture, microscopic
identification of acid
fast bacilli, or Xpert).
• No if the lower
quality reference
standard was used (that
Was there an appropriate
interval between index
test and reference stan-
dard?
• Yes if abdominal
ultrasound and the
reference standard(s)
(samples taken or
clinical diagnosis made)
were performed at the
same time or if the time
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(Continued)
• Unclear if the
study did not explicitly
state consecutive
enrolment or random
sampling, and it was
unclear how patients
were sampled.
ultrasound (and test
combinations) were
interpreted with
knowledge of the
reference standard
results.
• Unclear if
insufficient information
on how ultrasound (and
test combinations) was
interpreted.
is, not coupled with any
mentioned in higher
quality reference).
• Unclear if
insufficient information
on the reference
standard(s) used.
interval is less than one
week.
• No if the time
period between
ultrasound and the
reference standard is
more than one week.
• Unclear if
insufficient or no
information on the time
interval.
Was a case-control de-
sign avoided?
• Yes if a case-control
design was not used.
• No if patients with
known disease (cases)
and patients without the
disease (controls) were
clearly enrolled (such
that participants are
unrepresentative of the
spectrum of patients
seen in clinical practice).
• Unclear if the
study design used was
not clearly reported.
Pre-specified threshold
used?
• Yes if the study
states the use of one,
prespecified, cut-off
value, for example,
“abdominal lymph
nodes greater than
10mm in the shortest
diameter were deemed
as a positive result”.
• No if multiple cut-
off values were evaluated
and an optimal one
(based on maximising
test accuracy) was
subsequently chosen.
• Unclear if a cut-off
was used but was not
reported, or only one
cut-off value was
reported, but was not
explicitly pre-specified
in the study.
Reference standard re-
sults interpreted without
knowledge of the results
of index test?
• Yes if results of the
reference standard are
interpreted without
knowledge of
ultrasound results.
However, the clinical
reference standard may
incorporate ultrasound.
• No if results of the
reference standard were
interpreted with
knowledge of
ultrasound results
• Unclear if there is
insufficient information
on whether or not the
reference standard
results were interpreted
with knowledge of
ultrasound results
Did all patients receive a
reference standard?
• Yes if all
participants received a
reference standard.
• No if one or more
participants did not
receive a reference
standard.
• Unclear if there is
insufficient information
to determine whether or
not all patients received
a reference standard.
Did the study avoid in-
appropriate exclusions?
• Yes if no patients
were excluded after
inclusion in the study.
• No if specific
populations were
excluded (for example,
pregnant patients,
elderly), or patients with
high CD4 counts were
excluded because of low
Was incorporation bias
avoided (inclusion of in-
dex test as part of the ref-
erence standard)?
• Yes if abdominal
ultrasound was not used
as part of the reference
standard.
• No if abdominal
ultrasound formed part
of the reference
standard.
Did all patients receive
the same reference stan-
dard?
• Yes if study
participants received the
same reference standard
(regardless of ultrasound
result).
• No if participants
did not receive the same
reference standard.
• Unclear if there is
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(Continued)
clinical suspicion of TB.
• Unclear if
unreported or
insufficient information
given to make a
decision.
• Unclear if
insufficient information
given to make a
decision.
insufficient information
to determine whether or
not all patients received
the same reference
standard.
Were all patients in-
cluded in the analysis?
• Yes if all
participants recruited
into the study were
included in the analysis.
• No if some
participants recruited
into the study were
excluded in the analysis.
• Unclear if
unreported or
insufficient information
given to make a
decision.
Risk of bias¹(high, low,
or unclear)
Could the selection of
patients have introduced
bias?
Could the conduct or in-
terpretation of the in-
dex test have introduced
bias?
Could the reference stan-
dard, its conduct, or its
interpretation has intro-
duced bias?
Could the patient flow
have introduced bias?
Applicability concerns
(high, low, or unclear)
Are there concerns that
the included patients do
not match the review
question?
• High if
participants received
ultrasound in a tertiary
care (referral) centre.
• Low if participants
received ultrasound in
any setting.
• Unclear if
insufficient information
to make a decision.
Are there concerns that
the index test, its con-
duct, or interpretation
differs from the review
question?
• High if, for
example, specially
trained radiologists
performed the
ultrasound.
• Low if non-
radiologists performed
the ultrasounds.
• Unclear if
insufficient information
to make a decision.
Are there concerns that
the target condition as
defined by the reference
standard does not match
the review question?
• High if studies did
not speciate
mycobacteria isolated in
culture or clinically
diagnosed TB cases
were not followed up to
evaluate treatment
response.
• Low if studies did
speciate mycobacteria
isolated in culture or
clinically diagnosed TB
cases improved on anti-
TB therapy.
• Unclear if
insufficient information
to make a decision.
Not applicable
Abbreviations: TB: tuberculosis
¹Grading criteria for Risk of bias’ assessment
• If all signalling questions for a domain are answered yes’ then we will judge the risk of bias to be low’.
14Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive
adults (Protocol)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
• If any signalling question is answered no’ this will flag the potential for bias and we will judge risk of bias with a senior review
author.
• If all signalling questions or most of them were answered no’, then we will judge the risk of bias as high’.
• We will assign the unclear’ category when the study authors report insufficient data to permit a judgment.
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